KCT0002136已完成未知
A 8 week, randomized, double-blind, placebo-controlled clinical trial of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip for the evaluation of efficacy and safety on immune function
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 25(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1)Male or female subjects aged from 25 to 75 years old.
- •2)Screening white blood cell(WBC) ranged from 4X103 to 10X103cells/ul.
- •3)Stress self assessment scaled above strong(4 scales: none, moderate, strong, intense)
- •4)Subjects suffered from upper respiratory track infection or cold-related symptoms which have possibilities to cause upper respiratory track infection more than two times in the past one year. (*Tonsillitis, pharyngitis, laryngitis, sinusitis, otitis media, rhinitis, etc.)
- •5)Subjects who agreed to participate in this study and subjects(or legal representative) who signed written informed consent voluntarily.
排除标准
- •1)Subjects who are currently in the treatment of significant clinical disease related to acute or chronic cardiovascular system, immune system, respiratory system, liver biliary, kidney and urinary tract, nervous system, musculoskeletal disorders, psychic, infection and blood neoplastic. (However, subjects are possible to participate in the study by the discretion of the study director)
- •2)Subjects who have uncontrolled high blood pressure. (Higher than 160/100mmHg, measured 10 minutes after stabilizing)
- •3)Patients with uncontrolled diabetes. (180mg/dl or higher fasting glucose, or beginning of a new drug within 3months due to diabetes)
- •4)Subjects who got a vaccination within 3months before screening.
- •5)Subjects whose AST (GOT) or ALT (GPT) exceeds 120IU/L in the blood.
- •6)Male whose creatinine exceeds 1.0mg/dL in the blood and female whose creatinine exceeds 1.8mg/dL in the blood.
- •7)Subjects who have intaken or is intaking functional foods that have potential of affecting the immune system.
- •8)Subjects who have complained of severe gastrointestinal symptoms such as heartburn, indigestion.
- •9)Subjects who are planning a pregnancy, breastfeeding during this study.
- •10)Subjects who are sensitive to foods or have food allergies.
- •11)Subjects who are planning to participate other studies during this study.
- •12)Subjects who were involved in other human applied studies within 4weeks of this study begins.
- •13)Subjects who are deemed to be inappropriate to this human applied study.
研究者
相似试验
招募中
不适用
APGP for the evaluation of efficacy on immune function and immune cell activatioKCT0002551Yonsei University100
招募中
不适用
A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of IRT5 probiotics on atopic dermatitis in childreDiseases of the skin and subcutaneous tissueKCT0000914Korea Yakult Corporation110
已完成
不适用
Clinical trial for the evaluation of the efficacy and safety of live or killed Lactobacillus sakei Probio65 on atopic dermatitis in childreDiseases of the skin and subcutaneous tissueKCT0003928Probionic90
已完成
不适用
The efficacy and safety of weissella cibaria CMU on halitosisDiseases of th respiratory systemKCT0003301Dankook University60
招募中
不适用
The efficacy and safety of oraCMU on oral healthKCT0004291Seoul National University Dental Hospital100